NK stock forecast
Our latest prediction for NantKwest, Inc.'s stock price was made on the June 29, 2020 when the stock price was at 10.82$.
In the short term (2weeks), NK's stock price should outperform the market by 2.41%. During that period the price should oscillate between -11.87% and +14.56%.
In the medium term (3months), NK's stock price should underperform the market by -8.03%. During that period the price should oscillate between -39.45% and +30.07%.Get email alerts
Create a solid portfolio with NK
About NantKwest, Inc.
NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.67$ per share.
The book value per share is 2.29$
Three months stock forecastJune 29, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|